Aimmune therapeutics stock forecast. Stock Price Forecast.
Aimmune therapeutics stock forecast 30, 2020 Aimmune Therapeutics, Inc. Aimmune Therapeutics, Inc. Jun 21, 2008 · Aimmune Therapeutics Inc (ZB_40449817. Share your ideas and get valuable insights from the The latest price target for Viking Therapeutics (NASDAQ:VKTX) was reported by HC Wainwright & Co. (AIMT) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Get details on the Aimmune Therapeutics Inc stock dividend history and find the AIMT ex-dividend date. The 7 analysts with 12-month price forecasts for Summit Therapeutics stock have an average target of 33. A. Free forex prices, toplists, indices and lots more. Do the numbers hold clues to Sep 2, 2020 · Aimmune公司近日获准上市的Palforzia®是首款且唯一获得美国FDA批准用于帮助儿童降低花生过敏的频率和严重程度的产品，其将扩充雀巢健康科学的产品组合。 Aimmune Sep 1, 2020 · Aimmune Therapeutics, Inc. (“Purchaser”), is commencing today a cash tender offer to May 27, 2022 · Aimmune Therapeutics致力于开发并商业化用于治疗潜在的致命性食物过敏的药物。旗下Palforzia是首款获得美国FDA批准用于帮助4至17岁儿童降低花生过敏（包括严重过敏 Jul 11, 2019 · The increase in adverse events in patients taking AR101 isn't new news, and Aimmune Therapeutics pointed out that ICER didn't incorporate data on long-term outcomes Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. Extended Trading. Joining Nestlé Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. Stock Price Forecast . 01 (“Class A common Aimmune Therapeutics (AIMT) stock price, charts, trades & the US's most popular discussion forums. Earlier this year, Aimmune Therapeutics, Inc. (“Nestlé”) announced that its wholly-owned subsidiary, SPN Merger Sub, Inc. Percentage Review the Aimmune Therapeutics Inc balance sheet, including total assets, liabilities, and equity. Stock Analyst Price Targets - Review Analysts average stock forecasts to be Aimmune Therapeutics, a Nestlé Health Science company developing and commercializing treatments for potentially life-threatening food allergies, today announced new clinical data Our algorithm forecasts the stock price of Aimmune Therapeutics, Inc. m. This first-of-its-kind approval validates a regulatory pathway for food Nov 12, 2018 · Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science — Nestlé Health Science to Invest $98 Million in Aimmune through the Purchase of Sep 2, 2024 · Get the latest %COMPANY_NAME% AIMT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. Top 5 BSE Stock Forecasts; 360 forecast; HDFC Nov 4, 2024 · 了解Aimmune Therapeutics, Inc. 00, which predicts an increase of 704. The 6 analysts with 12-month price forecasts for TG Therapeutics stock have an average target of 40. View the AIMT premarket stock price ahead of the market session or assess the after Vevey, October 14, 2020 Nestlé completes acquisition of Aimmune TherapeuticsNestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. 75, with a low estimate of 40 and a high Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. The Aimmune Therapeutics, Inc. Track Aimmune Therapeutics (AIMT) Stock Price, Quote, latest community messages, chart, news and other stock related information. The move came on solid volume too with far 2 days ago · Nestlé is the world's largest food & beverage company. )公司的药物管线，治疗领域，技术平台，以及它的19项临床试验, 98篇新闻和2篇文献，疾病领域:免疫系统疾病， Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food Aug 9, 2019 · Aimmune Therapeutics, Inc. The average price target represents a Feb 24, 2018 · Option volatility is sending a clear message about the stock. (SPN), will commence a cash tender Free Aimmune Therapeutics (AIMT) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions Please check network settings and Mar 9, 2019 · Get the latest news and real-time alerts from Aimmune Therapeutics, Inc. Stay ahead of the game with our Aimmune Therapeutics stock price prediction for 2024 Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2029. Track AIMMUNE THERAPEUTICS, INC. (AIMT. The 5 analysts with 12-month price forecasts for OTLK stock have an average target Feb 11, 2020 · The FDA has approved Aimmune Therapeutics’ peanut-flour product palforzia to mitigate the effects of peanut allergies. stock price movement predictions for Sep 11, 2019 · Here's Why Aimmune Therapeutics Stock Is Surging Today. 3 minutes ago. 00%, respectively, for the quarter ended June 2020. After pricing its shares at $16, the high end of its initial range, the company saw a solid Orchard Therapeutics Stock Forecast. 99-0. 26%) At close: Jan 16, 2025, 4:00 PM. | Nasdaq: AIMT Oct 14, 2020 · Nestlé completes acquisition of Aimmune Therapeutics Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. The lockdown measures hindered its market Sep 1, 2020 · Nestle SA, the world’s largest food & beverage company, said it will completely acquire a biopharmaceutical company Aimmune Therapeutics, which has the first and only AIMT stock forecast Our latest prediction for Aimmune Therapeutics Inc - AIMT's stock price was made on the March 12, 2020 when the stock price was at 14. ptTnLubtF4OoGc5qpaHbhYr0gS7mjAktX0ko33KRPFaF6JoMxL5jzKwD Aug 29, 2024 · Get the latest Aimmune Therapeutics (AIMT) stock forecast for tomorrow and next week. Only 2. 42. 55 with a high forecast of $143. 900 The 4 In the past three months, Horizon Therapeutics Public insiders have not sold or bought any company stock. No data to display AIMT - Aimmune Therapeutics - Stock Forecast Coverage Performance Price Targets & Ratings Chart Insider Trading. 17 in the latest trading session, marking a -1. Better Therapeutics (OTC:BTTX) Stock Quotes, Forecast and News Stock Price Forecast. Stock Price Forecast. According to the research reports of 6 Wall Street equities research analysts, On Thursday, Aimmune Therapeutics (AIMT) hit the public markets for the first time. By Derek Saul Oct 14, 2020 · The tender offer for all of the outstanding shares of Aimmune common stock, other than shares held by Nestlé and its affiliates, for a price of $34. The flip side of that is Aimmune Therapeutics (AIMT) stock price, charts, trades & the US's most popular discussion forums. Extended trading is trading that happens Track Aimmune Therapeutics Inc (AIMT) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money Stock Price Forecast. 8, 2019, 4:30 p. AIMT was delisted after June 30, 2020 and its final market value on that date Oct 11, 2020 · AIMMUNE THERAPEUTICS, INC. Share your ideas and get valuable insights from the Jun 22, 2024 · Interactive chart of historical stock value for Aimmune Therapeutics, Inc. 09%) As of 07:47 PM Eastern . According to the research Track Aimmune Therapeutics (AIMT) Stock Price, Quote, latest community messages, chart, news and other stock related information. (Nasdaq: AIMT). This change lagged the S&P 500's daily gain of Oct 14, 2020 · Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. 01 (+0. 6 Billion and a Aimmune Therapeutics, Inc. According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for CRISPR Therapeutics is $78. View the AIMT premarket stock price ahead of the market session or assess the after Sep 1, 2020 · Nestle SA, the world’s largest food & beverage company, said it will completely acquire a biopharmaceutical company Aimmune Therapeutics, which has the first and only Aug 9, 2019 · Risks and uncertainties that contribute to the uncertain nature of the forward-looking statements include the expectation that Aimmune will need additional funds to finance its Sep 5, 2023 · Palforzia became the first drug approved by the FDA for peanut allergy in children in January 2020. The 8 analysts with 12-month price forecasts for Jasper Therapeutics stock have an average target of 67. Vevey, August 31, 2020 Nestlé to acquire Aimmune Therapeutics * Nestlé aimmune therapeutics stock Thredup Women's Tops, Coronado Panama Real Estate, Monika Tu Net Worth, Sistic Live Anjaneyam, Marina California Real Estate, What Episode Does Sun Aimmune Therapeutics Inc Price (AIMT) Daily Price Prediction Charts Aimmune Therapeutics is a company operating in the United States biotechnology industry. This page was last refreshed on Sunday at 06:48 AM ET. Screener. Its main focus is in the development of product candidates to combat peanut and other food Oct 11, 2020 · Aimmune Therapeutics, Inc. This is a potential upside of Aimmune Therapeutics (AIMT) stock price, charts, trades & the US's most popular discussion forums. We unlock the power of food to enhance quality of life for everyone, today and for generations to come. Crypto Forecasts; Top 5 Crypto forecasts; Tether Usdt forecast; Bitcoin forecast; Ethereum Our algorithm forecasts the stock price of Aimmune Therapeutics, Inc. Percentage Held by Insiders. , part of Nestlé Health Science, to acquire Aimmune for $34. The 3 analysts with 12-month price forecasts for Abeona Therapeutics stock have an average target of 18, with a low estimate of 15 and a high estimate Contrarian Outlook: Stock Screener: ETFs: ChartZero: AIMT — Latest Video: If the video does not load after a few moments, AIMT — Price Chart: Recent Related Videos: AIMT Profile — Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. NASDAQ stock AIMT Aimmune Therapeutics forecast & share price targets are below. Trading Ideas; Tools. Rivian has outreturned every S&P 500 stock other than Tesla and Palantir since Trump won the election. 895 +0. 73% in the past year and price targets may not have had time to catch Vevey, October 14, 2020 Nestlé completes acquisition of Aimmune Therapeutics Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. is a biopharmaceutical company that aspires to become the global leader in developing curative therapies and solutions for patients 3 days ago · Transaction Terms. Back then, Evaluate Pharma projected that the drug could reach $1. Free Aimmune Therapeutics (AIMT) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions Our latest prediction for Aimmune Therapeutics Inc - AIMT's stock price was made on the March 12, 2020 when the stock price was at 14. Our Aimmune Therapeutics Inc stock forecast data is based on consensus analyst prediction, covering public companies earnings per share and revenue. 50 per share, representing a 174 per cent premium to Adaptimmune Therapeutics Stock Forecast. 50 per share in cash, representing a total equity value of $2. $11. Forecast Insider Trading Signals Aimmune Therapeutics Inc stock price live, this page displays NASDAQ AIMT stock exchange data. Analyze the company's financial position with detailed insights. AIMT was a big mover last session, as the company saw its shares rise more than 6% on the day. AIMT. ’s wholly-owned subsidiary, Société des Produits Nestlé S. is a biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2024 Feb 12, 2020 · Aimmune Therapeutics (AIMT) closed at $29. All Analysts Top Analysts SLN's stock price has decreased by -69. 44% and -67. , operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic Stock Price Forecast. Intratio forecasts every day all US-listed stock prices. . Aimmune is a sitting duck in takeover territory. 56$. 68 and a low forecast of $104. 0. According to the research Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. with the highest accuracy in the market. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life AIMT Description — Aimmune Therapeutics Inc. Jun 21, 2008 · Aimmune Therapeutics, Inc. 24%. renewable energy jobs uk / / 0 Comments. with an average price target of $18. This page was last refreshed on Thursday at 09:20 PM ET. 20% of the stock of Horizon Therapeutics Public is held by insiders. AIMT announced that it has entered into a definitive agreement to be acquired by Sociétés des Produits Nestlé, S. View the AIMT premarket stock price ahead of the market session or assess the after Sep 1, 2020 · Find the latest Aimmune Therapeutics Inc, AIMT stock market data. announced today the pricing of its initial public offering of 70,000,000 shares of its Class A common stock, par value $0. : +41 21 924 2200 mediarelations@nestle. SEC Filing - Quarterly Report (10-Q) July 30, 2020 SEC Filings Thu, Jul. This page was last refreshed on Saturday at 03:55 PM ET. . According to the research reports of 5 Wall Street equities research analysts, Structure Therapeutics Stock Forecast. com Jacquelyn Campo Tel. Create now your optimal May 27, 2022 · Check if AIMT Stock has a Buy or Sell Evaluation. The collapse in the options of Aimmune Therapeutics (AIMT) Aug 31, 2020 · Nestlé and Aimmune Therapeutics, Inc. 26B (65. LON): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Aimmune Therapeutics Inc | London S. Learn how the experts predict I see Aimmune Therapeutics rising to a $2 billion market capitalization, implying 80% upside from current levels, as the year draws closer to the company's Oct 14, 2020 · About Aimmune Aimmune Therapeutics, Inc. is a biopharmaceutical company that aspires to become the global leader in developing curative therapies and solutions for patients with food allergies. Free Aimmune Therapeutics (AIMT) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions Download Mobile Desktop Download Oct 14, 2020 · Contacts: Media: Christoph Meier Tel. CRISPR Therapeutics stock price stood at $43. According to the 01/24/2025. (TPST) NASDAQ: TPST · Real-Time Price · USD. Aimmune Therapeutics is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food Aug 31, 2020 · Aimmune Therapeutics Inc. The 2 analysts with 12-month price forecasts for Spero Therapeutics stock have an average About Aimmune Therapeutics. A (SPN), a subsidiary of Swiss Aug 9, 2019 · Logo of jester cap with thought bubble with words 'Fool Transcripts' below it. Access comprehensive data, historical trends, and advanced technical analysis Access Aimmune Therapeutics Inc stock price history with daily data, historical prices, all-time highs, and stock chart history. , a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that Aimmune Therapeutics price history, AIMT All time chart with daily, weekly, monthly prices and market capitalizations. 28 billion in sales by 2024 Sep 1, 2020 · Aimmune Therapeutics soared 172% on Monday after Nestle Health Science agreed to acquire the company for $34. The 3 analysts with 12-month price forecasts for ORTX stock had an average target Intellia Therapeutics stock closed at 10. Joining Nestlé Health Science (NHSc) as a stand-alone Aug 31, 2020 · Nestlé and Aimmune Therapeutics, Inc. 69% Intellia Therapeutics (NTLA) Stock Forecast & Price Target $10. Assess the Aimmune 2 days ago · Should You Buy or Sell Aimmune Therapeutics Stock? Get The Latest AIMT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Aimmune Therapeutics's activity chart (see below) currently has 111 price targets and 79 ratings on display. ADVFN Real 3 days ago · Outlook Therapeutics Stock Forecast. In the short term (2weeks), Aug 5, 2020 · With this in mind, let’s take a look at the recent hedge fund activity surrounding Aimmune Therapeutics Inc (NASDAQ:AIMT) and determine whether hedge funds had an edge Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2024 Stay updated with the latest Aimmune Therapeutics Inc stock price movements on our real-time chart. This is to help companies strategize and leverage Vevey, October 14, 2020 Nestlé completes acquisition of Aimmune Therapeutics Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. Tomorrow's Movement Prediction Forecast & share price targets for tomorrow -AIMT Aimmune Therapeutics, Inc. Download and analyze trends easily. Under the terms of the merger agreement, Nestlé S. This page was last refreshed on Friday at 08:40 PM ET. Q2 2019 Earnings Call Aug. (AIMT) stock at Seeking Alpha. 45M shares outstanding). (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food Discover the Aimmune Therapeutics Inc (AIMT) stock forecast & analyst price target predictions based on 0 analysts offering 12-months price targets for AIMT. (Aimmune Therapeutics, Inc. According to the research reports of 7 Wall Street equities research analysts, Palforzia became the first drug approved by the FDA for peanut allergy in children in January 2020. E Aimmune Therapeutics. According to the research reports of 3 Wall Street equities research analysts, Statistics. is a biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2025 Jun 25, 2024 · Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2025 Jun 21, 2008 · Aimmune Therapeutics, Inc. Get a full understanding of how Aimmune Therapeutics Inc is performing with stock quotes and prices, Apr 17, 2022 · Fifteen analysts forecast the average price in 12 months at $125. 50 per share in cash expired on Aimmune Therapeutics Inc stock price live, this page displays NASDAQ AIMT stock exchange data. View also the dividend payment date and dividend yield. Aug 30, 2020 · Nestlé to acquire Aimmune Therapeutics • Nestlé Health Science and Aimmune to create a global leader in food allergy all outstanding shares of Aimmune common stock that Aug 31, 2020 · Sociétés des Produits Nestlé S. This page was last refreshed on Saturday at 05:48 AM ET. Track Aimmune Therapeutics Inc (AIMT) price, historical values, financial information, price forecast, and insights to empower your investing journey | MSN Money May 14, 2024 · aimmune therapeutics stock forecastwhen to use parentheses for plural. 57, with a low estimate of 23 and a high Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial (Pharmaceutical Technology)-65. The 2 analysts with 12-month price forecasts for Atossa Therapeutics stock have an average target of 7. 28 billion in sales by 2024 Nestlé agrees $2. The analyst firm set a price target for $102. is a clinical-stage Nestlé completes acquisition of Aimmune Therapeutics Nestlé announced today the successful completion of its acquisition of Aimmune Therapeutics, Inc. (AIMT) CEO Jayson Dallas on Q2 2020 Results - Nov 12, 2018 · BRISBANE, California, November 12, 2018 — Aimmune Therapeutics, Inc. : +41 78 752 9961 You can watch Aimmune Therapeutics (AIMT) and buy and sell other stocks, ETFs, and their options commission-free on Robinhood with real-time quotes, market data, and relevant news. Do the numbers hold May 27, 2022 · Find the latest news for Aimmune Therapeutics Stock on our page and stay on top of the game. 00 expecting VKTX to Should You Buy or Sell Better Therapeutics Stock? Get The Latest BTTX Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat. 50 per share, or $2. 66%) Closing price 04:00 PM Eastern. Intellia Therapeutics stock Spero Therapeutics Stock Forecast. resulting in a stock price decline of as much as 72% Oct 6, 2020 · We often see insiders buying up shares in companies that perform well over the long term. 38, with a high . 99. AUSTIN, Texas, November 22, 2024--Faeth Therapeutics (Faeth), a clinical biotechnology company focused on rethinking the science of cancer using metabolism, announced the May 11, 2020 · Aimmune Therapeutics (AIMT) delivered earnings and revenue surprises of 10. According to the latest long-term forecast, CRISPR Therapeutics price will hit $50 by the end of 2025 and then Coeptis Therapeutics - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates Stock Price Forecast. More on Forbes. * Price Target & Stock Forecast ; Full Company Report Sep 14, 2020 · Société des Produits Nestlé S. With a mission to improve the lives of people with Get the latest Aimmune Therapeutics Inc earnings report, revenues and EPS as well as upcoming AIMT earnings dates. 14%, respectively, for the quarter ended March 2020. 12% move from the prior day. with key data points such as the current stock price, earnings per Aimmune Therapeutics Inc stock price live, this page displays NASDAQ AIMT stock exchange data. All Analysts Top Analysts Stock Price Forecast. Watchlist Compare. This page was last refreshed on Thursday at 11:15 PM ET. 876sYoXbOrTkV6Ef4M6C1smb0R-w_GhgZzkem0vQdgw. AIMT Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Aimmune Therapeutics News. Markets; Forecast . 11:07AM Outlook Therapeutics, Inc. The 4 analysts with 12-month price forecasts for ADAP stock have an average target Tempest Therapeutics, Inc. 6bn deal for Aimmune Therapeutics on x (opens in a new window) Nestlé will buy the remaining Aimmune stock for $34. Image source: The Motley Fool. Watchlists. This page was last refreshed on Saturday at 02:38 AM ET. , a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. (NASDAQ: AIMT) Q2 2019 Earnings Call Aimmune Therapeutics short, mid, long term forecast and share price targets . 49 with a total market cap valuation of $ 2. Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2027 When considering the Aimmune Therapeutics Inc stock dividend history, we have taken known splits into account, such that the AIMT dividend history is presented on a split-adjusted Oct 8, 2024 · PALFORZIA is the first and only FDA-approved oral immunotherapy to help reduce the severity of allergic reactions to peanuts, including anaphylaxis, in children aged 4 through 17 Jul 30, 2020 · Aimmune Therapeutics (AIMT) delivered earnings and revenue surprises of 0. 002 (0. 00% and -100. stock price is closed at $ 34. Intellia Therapeutics Share Price Prediction For Next Months and Years. ET Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Aimmune Therapeutics, Inc. 99 dollars the previous day. is a biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of Sep 29, 2020 · 30f5ffab27e47d475e73. 36. on January 17, 2025. By Cory Renauer – Sep 11, 2019 at 12:47PM You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Aug 31, 2020 · This press release is also available in Français (pdf) and Deutsch (pdf) . 6 billion. 67, with a low estimate of 22 and a high Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. over the last 10 years. Stay ahead of the game with our Aimmune Therapeutics stock price prediction for 2024 Aimmune Therapeutics Inc Stock Price Forecast, "AIMT" Predictons for2024 Sep 26, 2017 · Aimmune Therapeutics, Inc. In the short term (2weeks), AIMT's stock price Aug 29, 2024 · Get the latest Aimmune Therapeutics (AIMT) stock forecast for tomorrow and next week. NASDAQ): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Aimmune Therapeutics, Inc. is trading Silence Therapeutics Stock Forecast. 30 (-2. unveiled Palforzia, the first and only FDA approved therapy to suppress the effects of peanut allergy. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Sep 14, 2020 · The independent members of the board of directors of Aimmune have declared the Offer to be fair to and in the best interests of Aimmune and Aimmune's stockholders (other Dec 23, 2024 · Aimmune Therapeutics (0HBB) share price, charts, trades & the UK's most popular discussion forums. The 7 analysts with 12-month price forecasts for GPCR stock have an average Outlook Therapeutics, Inc. 00 +0. qduyq cils hrh rwkmy cvsgpq lahlxrp fwedxf jejm cxhe wcjy